» Articles » PMID: 9007171

Immune Deficiency in Glycogen Storage Disease Type 1B

Overview
Journal Isr J Med Sci
Specialty General Medicine
Date 1996 Dec 1
PMID 9007171
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Patients with glycogen storage disease type 1B present the clinical features of glycogen storage disease type 1A. In addition, they are susceptible to recurrent bacterial infection and have recurrent oral ulcers and occasionally Crohn's-like disease. There features are due to immune dysfunction caused by a combination of neutropenia and impaired phagocytic functions.

Citing Articles

Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice.

Yiu W, Pan C, Allamarvdasht M, Kim S, Chou J Gene Ther. 2006; 14(3):219-26.

PMID: 17006547 PMC: 2507880. DOI: 10.1038/sj.gt.3302869.


The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression.

Belkaid A, Currie J, Desgagnes J, Annabi B Cancer Cell Int. 2006; 6:7.

PMID: 16566826 PMC: 1440869. DOI: 10.1186/1475-2867-6-7.